Voltalia SA (EPA:VLTSA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

It's been a sad week for Voltalia SA (EPA:VLTSA), who've watched their investment drop 11% to €6.00 in the week since the company reported its half-year result. The results were positive, with revenue coming in at €257m, beating analyst expectations by 2.9%. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the five analysts covering Voltalia provided consensus estimates of €506.0m revenue in 2025, which would reflect a chunky 10% decline over the past 12 months. Yet prior to the latest earnings, the analysts had been anticipated revenues of €582.4m and earnings per share (EPS) of €0.056 in 2025. So we can see that while the consensus made a substantial drop in revenue estimates, it no longer provides an earnings per share estimate. This suggests that the market is now more focused on revenues after the latest results.

See our latest analysis for Voltalia

There's been no real change to the consensus price target of €11.09, with Voltalia seemingly executing in line with expectations. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Voltalia, with the most bullish analyst valuing it at €21.80 and the most bearish at €7.00 per share. We would probably assign less value to the analyst forecasts in this situation, because such a wide range of estimates could imply that the future of this business is difficult to value accurately. With this in mind, we wouldn't rely too heavily the consensus price target, as it is just an average and analysts clearly have some deeply divergent views on the business.

Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that revenue is expected to reverse, with a forecast 20% annualised decline to the end of 2025. That is a notable change from historical growth of 18% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 2.8% per year. It's pretty clear that Voltalia's revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The clear low-light was that the analysts cut their forecast revenue estimates for Voltalia next year. On the negative side, they also downgraded their revenue estimates, and forecasts imply revenues will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

At least one of Voltalia's five analysts has provided estimates out to 2027, which can be seen for free on our platform here.

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Voltalia , and understanding it should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.